Last reviewed · How we verify

NCT05290896

Correlations Between Lens Star and Phacoemulsification.

Status unknown NA Last updated 22 March 2022
What this trial tests

NA trial testing Phacoemulsification in Cataract in 100 participants. Status unknown.

Timeline
20 February 2022
Primary endpoint
30 August 2022
15 September 2022

Quick facts

Lead sponsorBenha University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date20 February 2022
Primary completion30 August 2022
Estimated completion15 September 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 40 to 80, any sex, with Cataract or Lens Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess correlations between lens star biometry parameters and phacoemulsification in clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Phacoemulsification

Trials testing the same drug.

Other recruiting trials for Cataract

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290896.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing